AIDS TREATMENT NEWS #137, October 18, 1991
The Eighth International Conference on AIDS / Third STD World Congress, originally scheduled for Boston but moved due to U. S. travel restrictions on persons with HIV, will be held in Amsterdam on July 19-24, 1992. This conference will be jointly sponsored by Harvard University and the Dutch Foundation AIDS Conference 1992, and co-sponsored by the International AIDS Society and the World Health Organization. A new Call for Abstracts and Registration Brochure will be issued in December. The deadline for abstract submission and early registration is March 2, 1992.
For information on registering or on submitting abstracts, write to the address nearest you:
Harvard AIDS Institute 8 Story Street Cambridge, MA 02138
or
VIII International Conference on AIDS/III STD World Congress CLB Plesmaniaan 125 Postbus 9190 1006 AD Amsterdam Netherlands
** Antiviral Conference, San Francisco, November 14-16
The third annual "New Directions in Antiviral Chemotherapy," a conference sponsored by the Department of Medicine of the University of California San Francisco and by San Francisco General Hospital, will be held at the Sheraton Palace Hotel in San Francisco, Thursday November 14 through Saturday November 16. The program will include drugs in clinical trials and preclinical development for HIV and for other viruses, including herpes simplex, cytomegalovirus, and hepatitis. The program chairmen are John Mills, M. D., San Francisco General Hospital, and Lawrence Corey, M. D., University of Washington, Seattle.
The registration fee is $200, and continuing education credit is available.
For more information, contact Postgraduate Programs, 521 Parnassus Avenue, C-405, San Francisco, CA 94143-0656, 415/476- 5208.
** HIV and People of Color: West Coast Conference in November
A multicultural conference addressing issues of HIV and AIDS in communities of color will be held in Seattle, Washington, November 14, 15 and 16, at the Westin Hotel.
"Taking Charge: People of Color in Solidarity Against the HIV/AIDS Epidemic" is sponsored by the U. S. Public Health Service, and is intended to be a forum for African American, Asian/Pacific Islander, Latino/Chicano, and Native American/Alaska Native communities from Alaska, California, Hawaii, Idaho and Oregon.
The registration deadline for the conference is October 28, and space is limited. For more information, call 206/728-8911.
** Project Inform PI PERSPECTIVE October Issue
The October issue of PI Perspective, a newsletter published three times a year by Project Inform, includes major articles on: expedited drug approval; how ddI was approved and what the process means for the future; immune-based therapies; aggressive early intervention; and total parenteral nutrition. There is also a guide to opportunistic infections, a "clinical update" with brief descriptions of a number of experimental drugs now being developed, and several shorter notes and articles.
PI Perspectives is available without charge, but a donation is appreciated. To obtain a copy, call the Project Inform hotline, 800/822-7422 (U. S. except California), 800/334-7422 (California only), or 415/558-9051. Hours are 10 a.m. to 4 p.m. Monday through Friday and 10 a.m. to 1 p.m. Saturday, Pacific time.
[sysop note: for a quick glance, look at the display here of this latest issue of PI Perspective #11]
** DATA: New Organization Announces Hypericin Fund, Seeks Research Reform
DATA (Direct Action for Treatment Access), a new treatment activist organization including AIDS and other major diseases, recently began as a project of the nonprofit PATH Foundation, an organization which has worked for two years to promote research into passive immunotherapy for AIDS. DATA is seeking donations for a "Special Trials for Alternative Treatments Fund"; donations may be directed for use in research or research advocacy for hypericin, an experimental HIV treatment, or for passive immunotherapy; or donors may leave their funds unrestricted for use as the board believes best. Other treatment research projects may be added in the future.
DATA has also started a treatment newsletter, Access, which is available through the address below.
At this time the board of DATA consists of Steven Wm. Fowkes, editor of Forefront, a health newsletter; James P. Driscoll, Ph.D., best known for his work on the "Campbell bill" for faster access to drugs for life-threatening conditions (for background on the Campbell bill, see AIDS TREATMENT NEWS #136); and Dale Gieringer, Ph.D., author of papers on regulatory reform, some of them published by the Cato Institute, a public-policy foundation dedicated to limited government and free-market ideas. Steven Fowkes provided major assistance to AIDS TREATMENT NEWS on one of our earliest major articles, on BHT as a potential HIV or herpes treatment (issue #10, August 15, 1986).
Membership in DATA is $20 per year. The organization is also seeking volunteers. For more information, send a self- addressed stamped envelope to: DATA, P. O. Box 60391, Palo Alto, CA 94306, or phone 415/323-6051.
911018
ATN13705
Copyright © 1991 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .